83
75
Growth Score 83 in past quarter
-7 pts
Heat Score 75 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
429870
Epeius Pharma is a biotechnological health care company that delivers neurological disorders treatment through therapeutics.
About the Company
Epeius pharma is a cell and gene therapy company that is developing next-generation biological vehicles for therapeutic protein delivery into the central nervous system. The blood-brain barrier, which tightly regulates the transport of molecules to the brain and blocks the transport of most large, charged, and hydrophilic molecules, which are
common features of therapeutic agents, makes efficient and predictable therapeutics delivery particularly difficult in neurological diseases. Protein replacement therapy is limited by the lack of effective CNS delivery methods, and there is still an unmet need for neurological disorder treatment.
